According to the latest report by IMARC Group, titled, “Acne Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027“, The global acne drugs market size reached US$ 6.1 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 9.1 Billion by 2027, exhibiting a growth rate (CAGR) of 7.4% during 2022-2027.
Acne drugs are medications used to treat a dermatological infection caused by the inflammation in the hair follicles on the skin. It is generally due to hormonal imbalance, oily skin, accumulation of dead skin cells, bacteria, stress, inadequate water intake, and excessive consumption of sugars, salts, or carbohydrates. Few acne drugs are topical medications, such as retinoids, salicylic and azelaic acid-based ointments, and dapsone-based gels, coupled with antibiotics, anti-androgen agents, and isotretinoin. These drugs reduce oil production in the body, accelerate skin cell turnover, reduce acne breakouts, scarring, damage the skin, and prevent inflammation.
Request Free Sample Report (Exclusive Offer on this report): https://www.imarcgroup.com/acne-drugs-market/requestsample
Acne Drugs Market Trends and Drivers:
The growing incidences of skin-related diseases, such as acne vulgaris, are driving the acne drug market. Moreover, increasing awareness towards the benefits of using premium skin care products and the emergence of effective therapeutics and treatments with lower side effects are augmenting the market growth. Additionally, the growing traction for products containing natural ingredients has compelled the manufacturers to develop products infused with natural herbs and organic ingredients to treat acne. Furthermore, elevating consumer disposable income levels and the growing popularity of customized acne drugs as per the user’s skin type, are expected to propel the acne drugs market.
The competitive landscape of the industry has also been examined along with the profiles of the key players.
- Allergan Plc
- Bausch Health Companies Inc.
- Bayer Aktiengesellschaft
- Cipher Pharmaceuticals Inc.
- Galderma Holding SA
- Johnson & Johnson
- Pfizer Inc.
- Reckitt Benckiser Group Plc
- Skinvisible Pharmaceuticals Inc.
- Sun Pharmaceutical Industries Limited
- Teva Pharmaceutical Industries Ltd.
Acne Drugs Market Report 2022-2027 Competitive Analysis and Segmentation:
The report has segmented the market based on acne type, drug class, drug type and route of administration.
Breakup by Acne Type:
Breakup by Drug Class:
- Hormonal Agents
- Combination Drugs
Breakup by Drug Type:
- OTC Drugs
- Prescription Drugs
Breakup by Route of Administration:
Breakup by Region:
- North America
- Latin America
- Middle East and Africa
Ask Analyst for Customization and Browse full report with TOC & List of Figure: https://www.imarcgroup.com/acne-drugs-market
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
30 N Gould St, Ste R
Sheridan, WY (Wyoming) 82801 USA
Tel No:(D) +91 120 433 0800
Americas: – +1 631 791 1145 | Africa and Europe: – +44-702-409-7331 | Asia: +91-120-433-0800